isoxazoles has been researched along with Catatonia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conway, C; Cristancho, P; Jewkes, D; Mon, T | 1 |
Bourgeois, JA; Kahn, DR; Palomino, A; Xiong, GL | 1 |
Gupta, A; Kulkarni, SK; Kumar, A | 1 |
Coffey, MJ | 1 |
4 other study(ies) available for isoxazoles and Catatonia
Article | Year |
---|---|
Successful use of right unilateral ECT for catatonia: a case series.
Topics: Adolescent; Adult; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Catatonia; Depressive Disorder, Major; Electroconvulsive Therapy; Female; GABA Modulators; Humans; Isoxazoles; Lorazepam; Lupus Erythematosus, Systemic; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Schizophrenia, Catatonic; Seizures; Treatment Outcome; Young Adult | 2014 |
Antipsychotic induced catatonia: a case of probable dementia with Lewy bodies.
Topics: Antipsychotic Agents; Catatonia; Hallucinations; Humans; Isoxazoles; Lewy Body Disease; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines | 2009 |
Targeting oxidative stress, mitochondrial dysfunction and neuroinflammatory signaling by selective cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Caspase 3; Catatonia; Cyclooxygenase 2 Inhibitors; Inflammation; Isoxazoles; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mitochondria; Motor Activity; MPTP Poisoning; NADH Dehydrogenase; Neuroprotective Agents; Nitrites; Nitrobenzenes; Oxidative Stress; Signal Transduction; Sulfhydryl Compounds; Sulfonamides; Tetrazolium Salts; Thiazoles; Thiobarbituric Acid Reactive Substances; Transcription Factor RelA | 2011 |
Catatonia and encephalopathy associated with paliperidone palmitate.
Topics: Aged; Antipsychotic Agents; Catatonia; Female; Humans; Isoxazoles; Lorazepam; Male; Neuroleptic Malignant Syndrome; Palmitates; Psychotic Disorders; Pyrimidines; Schizophrenia | 2012 |